文献速递瓣膜外科

主动脉瓣修复联合瓣环成形术的临床结果

Aortic valve repair with annuloplasty.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2025-01-01

无手术死亡,8年总生存率97.4±2.6%,重度反流复发再手术与瓣环≥28 mm及未常规使用瓣叶卡尺相关。

要点

  • 外环Teflon条瓣环成形术安全,无手术死亡,8年生存率97.4%。
  • 瓣环≥28 mm与未常规使用瓣叶卡尺预测重度反流复发再手术。
  • 术后8年免于心内膜炎98.3%,免于血栓栓塞100%。

核心结论

  • 外环Teflon条瓣环成形术安全,10年总生存率、免于心内膜炎和免于血栓栓塞率高。
  • 重度主动脉瓣反流复发再手术可能与患者选择和学习曲线有关。

研究设计与样本

  • 外环由8-9 mm Teflon条制成,使瓣环直径减至21-23 mm;2018年前未使用瓣叶卡尺。

主要发现

  • 72.1%患者有重度主动脉瓣反流,42.6%同期行主动脉上动脉瘤修复。
  • 无手术死亡;仅1例患者残余反流超过中度。
  • 8年总生存率97.4±2.6%,免于心内膜炎98.3±1.7%,免于血栓栓塞100%。
  • 重度反流复发需再手术由瓣环≥28 mm(P<0.01)和未常规使用瓣叶卡尺(P=0.03)预测。

临床怎么用

  • 对于主动脉瓣反流患者,可考虑外环Teflon条瓣环成形术联合瓣叶修复。
  • 术中应常规使用瓣叶卡尺评估有效高度,并注意瓣环≥28 mm患者的复发风险。

局限性

  • 回顾性单中心研究,样本量61例,可能存在选择偏倚。
  • 瓣叶卡尺2018年前未使用,可能影响学习曲线分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Aortic valve repair procedures for aortic valve regurgitation have been progressively adopted in the last decades. We analysed our results with an external ring annuloplasty and/or leaflet repair. METHODS: From April 2014 to December 2023, 61 consecutive patients underwent aortic valve repair with external Teflon ring annuloplasty. The external ring was made of an 8-9 mm Teflon strip, to reduce the annulus diameter between 21 and 23 mm. Cusp effective height (eH) was assessed with a caliper (not used before 2018), and any cusp prolapse was corrected by free margin plication, to obtain a 9-10 mm eH for all cusps. RESULTS: Patients (72.1%) had severe aortic regurgitation (AR), and associated supracoronary aneurysm repair was performed in 42.6%. No operative death occurred; residual AR more-than-moderate was present in one patient only. The 8-year overall survival was 97.4 ± 2.6%, freedom from endocarditis 98.3 ± 1.7% and freedom from thromboembolism 100%. Recurrence of severe AR with need for reoperation was predicted by the presence of a particularly enlarged aortic annulus (≥28 mm, P < 0.01) and the non-routinary use of cusp caliper (P = 0.03). CONCLUSIONS: The external Teflon ring annuloplasty appears a safe procedure with high overall survival, freedom from endocarditis and freedom from thromboembolism at 10 years. Recurrence of severe AR could be related to patient selection and learning curve.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Irace FG, Chirichilli I, Scaffa R, et al. Aortic valve repair with annuloplasty. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 40600917. doi:10.1093/icvts/ivaf146

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。